Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Diabetic Cardiomyopathy (RECOGITO)
NCT01803828Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- May 2014
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tadalafil in diabetic cardiomyopathy (DCM), sponsored by Sapienza University of Rome. Started May 2014; status: completed.
02
Drugs
tadalafil
03
Conditions
diabetic cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01803828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01803828.